APA (7th ed.) Citation

Verstockt, B., Pivorunas, V., Mahi, N. A., Smaoui, N., Guay, H., Kennedy, N. A., . . . Vermeire, S. (2024). Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies. Journal of Crohn's & Colitis, 18(4), 493. https://doi.org/10.1093/ecco-jcc/jjad170

Chicago Style (17th ed.) Citation

Verstockt, Bram, et al. "Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies." Journal of Crohn's & Colitis 18, no. 4 (2024): 493. https://doi.org/10.1093/ecco-jcc/jjad170.

MLA (9th ed.) Citation

Verstockt, Bram, et al. "Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies." Journal of Crohn's & Colitis, vol. 18, no. 4, 2024, p. 493, https://doi.org/10.1093/ecco-jcc/jjad170.